The Role of Aβ-Induced Calcium Dysregulation in the Pathogenesis of Alzheimer's Disease

被引:67
|
作者
Small, David H. [1 ]
Gasperini, Robert [1 ]
Vincent, Adele J. [1 ]
Hung, Amos C. [1 ]
Foa, Lisa [1 ]
机构
[1] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7001, Australia
关键词
Alzheimer's disease; amyloid; calcium; neurotoxicity; synaptic plasticity; MOLECULAR ISOFORM DISTRIBUTION; NEURONAL CA2+ HOMEOSTASIS; AMYLOID-BETA; CEREBROSPINAL-FLUID; CHANNEL FORMATION; ACETYLCHOLINE-RECEPTORS; INTRACELLULAR CALCIUM; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS;
D O I
10.3233/JAD-2009-0951
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although many of the biochemical mechanisms which regulate production or clearance of the amyloid-beta protein (A beta) of Alzheimer's disease (AD) are now well understood, the mechanism of A beta neurotoxicity remains unclear. A number of studies have shown that A beta can disrupt neuronal Ca2+ homeostasis by inducing influx of extracellular Ca2+ into the neuronal cytoplasm. Ca2+ is known to play an important role in neuronal excitability, synaptic plasticity and neurotoxicity. Therefore, A beta-induced Ca2+ dysregulation may contribute to many of the cognitive and neuropathologic features of AD. In vitro studies show that A beta can increase ion permeability in lipid membranes. This increased permeability is reportedly associated with the formation of artificial ion pores formed from A beta oligomers. However, a number of other studies show that A beta can activate endogenous ion channels on the cell surface. There is also increasing evidence that presenilin mutations alter intracellular Ca2+ stores. It is likely that elucidation of the mechanism by which A beta and presenilin cause Ca2+ dysregulation in neurons will help to identify new drug targets for the treatment of AD.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 50 条
  • [1] Role of GPCR signaling and calcium dysregulation in Alzheimer's disease
    Sushma
    Mondal, Amal Chandra
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 101
  • [2] Dysregulation of calcium in Alzheimer's disease
    Brzyska, M
    Elbaum, D
    [J]. ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2003, 63 (03) : 171 - 183
  • [3] Calcium dysregulation in Alzheimer's disease
    Bojarski, Lukasz
    Herms, Jochen
    Kuznicki, Jacek
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (4-5) : 621 - 633
  • [4] Role of calcium dysregulation in Alzheimer's disease and its therapeutic implications
    Joshi, Maithili
    Joshi, Siddhi
    Khambete, Mihir
    Degani, Mariam
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 101 (02) : 453 - 468
  • [5] Dysregulation of Calcium Homeostasis in Alzheimer’s Disease
    David H. Small
    [J]. Neurochemical Research, 2009, 34 : 1824 - 1829
  • [6] Dysregulation of Calcium Homeostasis in Alzheimer's Disease
    Small, David H.
    [J]. NEUROCHEMICAL RESEARCH, 2009, 34 (10) : 1824 - 1829
  • [7] Dysregulation of Intracellular Calcium in Alzheimer's Disease
    Bacskai, Brian J.
    Kuchibhotla, Kishore V.
    Lattarulo, Carli
    Hyman, Bradley T.
    [J]. BIOPHYSICAL JOURNAL, 2010, 98 (03) : 3A - 3A
  • [8] Glial calcium dysregulation in Alzheimer's disease
    Genazzani, A.
    [J]. GLIA, 2015, 63 : E40 - E40
  • [9] Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease
    Popugaeva, Elena
    Pchitskaya, Ekaterina
    Bezprozvanny, Ilya
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2018, 29 (12) : 1176 - 1188
  • [10] Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease
    Magi, Simona
    Castaldo, Pasqualina
    Macri, Maria Loredana
    Maiolino, Marta
    Matteucci, Alessandra
    Bastioli, Guendalina
    Gratteri, Santo
    Amoroso, Salvatore
    Lariccia, Vincenzo
    [J]. BIOMED RESEARCH INTERNATIONAL, 2016, 2016